| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $269.78M | $232.66M | $173.75M | $121.63M | $55.91M |
| SG&A | $63.58M | $43.28M | $34.38M | $26.21M | $19.64M |
| Operating Income | -$333.36M | -$275.94M | -$208.13M | -$147.84M | -$75.55M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | – | – | – | – |
| Net Income | -$328.94M | -$255.86M | -$192.41M | -$140.24M | -$72.27M |
| EPS (basic) | -2.1600 | -1.9400 | -2.4200 | -2.3900 | -1.8700 |
| EPS (diluted) | -2.1600 | -1.9400 | -2.4200 | -2.3900 | -1.8700 |
| Shares (diluted) | $128.90M | $103.86M | $79.66M | $58.74M | $38.73M |